Nrl Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Nrl monoclonal antibodies for various research applications. Nrl monoclonal antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nrl, or neural retina leucine zipper, is a transcription factor that plays a critical role in the development and function of photoreceptor cells in the retina. Nrl regulates genes involved in phototransduction and has significant implications in retinal diseases when dysregulated. Understanding Nrl function advances research in retinal biology and potential therapeutic strategies for vision-related disorders. Researchers worldwide utilize Nrl monoclonal antibodies to investigate retinal development pathways and disease mechanisms. Nrl research contributes to breakthroughs in understanding photoreceptor differentiation and maintenance. Current studies focusing on Nrl expression patterns help identify new therapeutic targets for retinal disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge of retinal development and disease treatment strategies.